Integral Health Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Integral Health Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-80,000	Closed	-$1.44M	–	88
2020 Q3	$1.44M	Sell	80,000 -30,000	-27%	-$621K	0.44%	63
2020 Q2	$2.79M	Sell	110,000 -75,000	-41%	-$1.62M	0.84%	46
2020 Q1	$3.4M	Sell	185,000 -15,000	-8%	-$292K	1.5%	30
2019 Q4	$4.41M	Buy	+200,000	New	+$4.02M	1.72%	22

Other funds holding DRNA

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Integral Health Asset Management's DRNA Position: Q4 2020 in Review

Integral Health Asset Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2020, closing a stake of 80,000 shares — an estimated $1.44M sold.

Integral Health Asset Management first reported a position in DRNA in Q4 2019 and held it in 4 quarters. The position peaked at $4.41M in Q4 2019. 173 funds tracked by Wall St. Rank hold DRNA as of Q4 2020.

Integral Health Asset Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Integral Health Asset Management sold 80,000 Dicerna Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.44M.
Integral Health Asset Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 4 quarters.
Integral Health Asset Management's Dicerna Pharmaceuticals, Inc. position peaked at $4.41M in Q4 2019.
173 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2020.

Based on Integral Health Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.